Table 2.
Clinicopathologic characteristics of 100 cases enrolled for validation
| Clinicopathologic characteristics | n | |
|---|---|---|
| Survival | Survival | 76 |
| Death | 24 | |
| Gender | Female | 43 |
| Male | 57 | |
| Histology | Tumor | 54 |
| Carcinoma | 46 | |
| Myasthenia gravis | No | 69 |
| Yes | 31 | |
| WHO histological types | A/AB/B1/B2/B3 | 54 |
| C | 46 | |
| Masaoka stage | I–II | 37 |
| III–IV | 63 | |
| Radiotherapy | No | 66 |
| Yes | 34 | |
| Chemotherapy | No | 69 |
| Yes | 31 | |
| Beta value | WHO histological types A–B3 (median/range) | WHO histological type C (median/range) |
| cg05784862 KSR1 | 61.5 (19–70) | 42 (0–49) |
| cg07154254 ELF3 | 30 (8–40) | 16 (0–20) |
| cg02543462 IL1RN | 67 (13–80) | 24.5 (0–40) |
| cg06288355 RAG1 | 40 (27–88) | 77.5 (60–92) |